HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver involvement in patients with erythropoietic protoporphyria.

AbstractBACKGROUND:
In erythropoietic protoporphyria (EPP), which presents with severe painful phototoxicity, progressive deposition of protoporphyrins in hepatocytes and bile canaliculi may result in liver disease. Clinically EPP related liver disease ranges from mildly elevated liver enzymes to cirrhosis and acute cholestatic hepatic failure. The prevalence of liver disease in EPP, and factors predicting the risk of developing liver disease, have not been defined in a large series of unselected EPP patients.
AIM:
To determine the prevalence of liver disease in EPP-patients.
METHODS:
A single-center prospective unselected cohort study of 114 adult EPP patients, who underwent routine laboratory testing, abdominal ultrasonography and transient elastography to assess the presence of steatosis (controlled attenuation parameter,dB/m) and liver stiffness (kPa).
RESULTS:
114 adult EPP patients were included. Elevated liver enzymes were found in 6.2% of the patients. Liver steatosis was detected in 29.0%, and significant fibrosis as assessed with liver stiffness measurements was present in 9.6% of patients. BMI positively predicted CAP-values (p = 0.026); and protoporphyrin IX levels (p = 0.043) positively predicted liver stiffness.
CONCLUSIONS:
This study demonstrates a prevalence of hepatic steatosis and fibrosis in adult EPP-patients comparable to that found in the general population. Protoporphyrin IX levels correlate with increased liver stiffness in EPP.
AuthorsDebby Wensink, Sandra Coenen, J H Paul Wilson, Margreet A E M Wagenmakers, Janneke G Langendonk
JournalDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver (Dig Liver Dis) Vol. 54 Issue 4 Pg. 515-520 (Apr 2022) ISSN: 1878-3562 [Electronic] Netherlands
PMID34475006 (Publication Type: Journal Article)
CopyrightCopyright © 2021. Published by Elsevier Ltd.
Topics
  • Adult
  • Cohort Studies
  • Humans
  • Liver (diagnostic imaging)
  • Liver Diseases
  • Prospective Studies
  • Protoporphyria, Erythropoietic (complications, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: